- Home
- SLF vs RGC Comparison
SLF vs RGC Comparison
Compare SLF & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLF
- RGC
- Stock Information
- Founded
- SLF 1871
- RGC 2014
- Country
- SLF Canada
- RGC Hong Kong
- Employees
- SLF N/A
- RGC N/A
- Industry
- SLF Advertising
- RGC Medicinal Chemicals and Botanical Products
- Sector
- SLF Consumer Discretionary
- RGC Health Care
- Exchange
- SLF Nasdaq
- RGC Nasdaq
- Market Cap
- SLF 37.5B
- RGC 38.6B
- IPO Year
- SLF N/A
- RGC 2021
- Fundamental
- Price
- SLF $62.02
- RGC $13.70
- Analyst Decision
- SLF Buy
- RGC
- Analyst Count
- SLF 1
- RGC 0
- Target Price
- SLF $88.00
- RGC N/A
- AVG Volume (30 Days)
- SLF 478.5K
- RGC 2.8M
- Earning Date
- SLF 08-07-2025
- RGC 06-30-2025
- Dividend Yield
- SLF 3.89%
- RGC N/A
- EPS Growth
- SLF 3.59
- RGC N/A
- EPS
- SLF 3.81
- RGC N/A
- Revenue
- SLF $23,434,793,186.00
- RGC N/A
- Revenue This Year
- SLF N/A
- RGC N/A
- Revenue Next Year
- SLF $4.18
- RGC N/A
- P/E Ratio
- SLF $16.29
- RGC N/A
- Revenue Growth
- SLF 7.25
- RGC N/A
- 52 Week Low
- SLF $46.41
- RGC $0.08
- 52 Week High
- SLF $66.81
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- SLF 39.98
- RGC 44.61
- Support Level
- SLF $61.28
- RGC $13.54
- Resistance Level
- SLF $66.81
- RGC $30.00
- Average True Range (ATR)
- SLF 0.98
- RGC 4.97
- MACD
- SLF -0.42
- RGC -1.47
- Stochastic Oscillator
- SLF 13.29
- RGC 20.91
About SLF Sun Life Financial Inc.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 38% of adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 20% of the firm's adjusted earnings in 2024. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.1 trillion total assets under management or administration at the end of 2024 and represents around 34% of the firm's earnings.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.